Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

fidji

14 POSTS

Exclusive articles:

SKN | Attovia Therapeutics Expands IPO by 45% as Investor Demand Lifts Planned Raise to $289 Million

Clinical-stage biotechnology company Attovia Therapeutics has significantly expanded its planned initial public offering, increasing the size of the deal by 45% as investor demand...

SKN | Market Technology Acquisition Raises $200 Million in IPO to Target U.S. Equities Clearing Infrastructure

Market Technology Acquisition has completed its initial public offering, raising $200 million as the special purpose acquisition company (SPAC) prepares to pursue opportunities in...

SKN | ServiceNow Shares Slide as Investors Focus on AI Workflow Growth Ahead of Earnings

ServiceNow, Inc. shares declined during early trading on July 22, 2026, falling more than 4% as investors positioned ahead of the company's upcoming second-quarter...

SKN | ACM Research Shares Surge Ahead of Earnings as Semiconductor Equipment Demand Drives Momentum

ACM Research Rallies on Semiconductor Optimism ACM Research, Inc. (NASDAQ: ACMR) posted strong gains during Tuesday's trading session, with shares rising 11.66% to $92.14, reflecting...

SKN| Taiwan Semiconductor Shares Rise Ahead of Q2 Earnings as AI Demand Continues to Drive Growth

Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) is drawing heightened investor attention ahead of its second-quarter 2026 earnings report, scheduled for July 16, as...

Breaking

SKN | City Therapeutics Sets Terms for $175 Million IPO as RNAi Pipeline Advances

City Therapeutics, a clinical-stage biotechnology company developing RNA interference...

SKN | TRex Bio Raises $117 Million in Nasdaq IPO to Advance Autoimmune Disease Treatments

TRex Bio, a clinical-stage biotechnology company developing treatments for...

SKN | Retension Pharmaceuticals Raises $45 Million in Upsized IPO to Advance Hypertension Drug

Retension Pharmaceuticals, a clinical-stage biotechnology company developing a treatment...

SKN | XFUNDS Launches VGTX to Combine Technology Stocks with Options-Based Income

Key Points: XFUNDS has launched the XFUNDS Technology Income...
spot_imgspot_img